僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Galiximab （IDEC 114） is a primatized immunoglobulin G1 （IgG1） lambda monoclonal antibody directed against the CD80 antigen. Galiximab has variable regions are primatized （cynomologous monkeys）, and the constant regions are human. Galiximab can be used in research of B-cell lymphoma